Heron Therapeutics, Inc.HRTXNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-57.37%
↓ 1664% below average
Average (9y)
-3.25%
Historical baseline
Range
High:68.55%
Low:-57.37%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -57.37% |
| 2023 | -52.68% |
| 2022 | -36.78% |
| 2021 | -25.05% |
| 2020 | 4.27% |
| 2019 | 19.53% |
| 2018 | 1.05% |
| 2017 | 34.38% |
| 2016 | 68.55% |
| 2015 | 11.58% |